Top Industry Leaders in the Fibromuscular Dysplasia Market
Latest Fibromuscular Dysplasia Companies Update
June 2023: An international cooperation agreement for the research, development, and marketing of NRX-101 for suicidal treatment-resistant bipolar disorder (S-TRBD) for worldwide markets was announced by Lotus Pharmaceuticals, a multinational pharmaceutical company; Alvogen, a privately held pharmaceuticals company based in the United States; and NRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company. Upon successful completion of both the Type B meeting with the U.S. Food and Drug Administration (FDA) and a successful read-out from the ongoing Phase 2b/3 clinical trial in S-TRB, NRx will be entitled to receive an initial payment of $10 million under the terms of the agreement, which pertains to NRX-101 for the U.S. market. Upon NRX-101's FDA clearance, NRx would earn an extra $5 million. Bonus milestone payments would go up to $330 million based on specified net sales milestones.
April 2023: In a medical breakthrough, a case of fibromuscular dysplasia (FMD) has been reported, which was published on Cureus, a division of Springer Nature Group. The patient presented with symptoms in the mid to distal section of the left anterior descending (LAD) artery. The patient's development of acute coronary syndrome (ACS) as a result of this rare event highlights the seriousness of the situation. An unexpected turn of events was uncovered when the patient's clinical complaints were being investigated. An unanticipated discovery was made that suggests both renal arteries may be involved with FMD. This fortunate discovery not only makes the issue more complicated, but it also highlights the vital need for extensive assessment and investigation when dealing with FMD patients.List of Fibromuscular Dysplasia Key companies in the market
- Alkermes Pharma Ireland Limited
- ALVOGEN
- Aspen Surgical Products, Inc.
- AstraZeneca
- B. Braun Melsungen AG
- Bayer Healthcare Pharmaceuticals Inc.
- Becton
- Dickinson and Company
- Bristol-Myers Squibb
- Dainippon Sumitomo Pharma Co.Ltd
- Ethicon, Inc.
- Merck
- Novartis
- Pfizer
- Sanofi-Aventis
- Smith & Nephew plc;
- Medtronic
- Stryker Corporation
- Watson Pharma Private Limited.